Dr. David P. Ryan

Dr. Wolpin received his medical degree from Harvard Medical School in 2001. He subsequently completed his residency in Internal Medicine at Brigham and Women's Hospital, and his fellowship in Medical Oncology at the Dana-Farber Cancer Institute. He joined the staff of DFCI and Brigham and Women's Hospital in 2007, where he is a medical oncologist and clinical investigator in the Center for Gastrointestinal Oncology. His research focuses on biomarkers and novel therapeutics in gastrointestinal malignancies, and mechanisms by which lifestyle factors interact with malignant risk and progression. Dr. Wolpin is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Alexander Raufi is a Hematologist Oncology specialist and an Oncologist in Providence, Rhode Island. Dr. Raufi is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Stomach Cancer, and Neuroendocrine Tumor.

Elliott Anderson is an Oncologist in Dartmouth, Massachusetts. Dr. Anderson is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. His top areas of expertise are Anal Cancer, Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Pancreatic Ductal Adenocarcinoma. Dr. Anderson is currently accepting new patients.